Market Place
Sourcing Support
All News #Library
Alexion’s Biologics Ultomiris Receives Suppl Approval in US
27 Jun 2025 //
FDA
Alexion’s Biologics Soliris Receives Suppl Approval in US
27 Jun 2025 //
FDA
Alexion`s Biologic Soliris (Eculizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Alexion`s Biologic Ultomiris (Ravulizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Alexion Pharma`s Biologic Strensiq (asfotase alfa) Receives Approval in US
10 Jul 2024 //
FDA
Alexion Pharma`s Biologic Kanuma (sebelipase alfa) Receives Approval in US
10 Jul 2024 //
FDA
Alexion Pharma`s Biologic Soliris (exulizumab) Receives Approval in US
28 Jun 2024 //
FDA
Alexion`s Biologic Ultomiris (ravulizumab-cwvz) Receives Approvals in the US
28 Jun 2024 //
FDA
Alexion Pharma`s Biologic Soliris (eculizumab) Receives Approval in the U.S.
09 Feb 2024 //
FDA
Alexion Pharmaceuticals`s Ravulizumab Receives Supplemental Approval in U.S.
27 Apr 2022 //
FDA
Alexion`s Generic Ultomiris (Ravulizumab) Receives Approval in the US
22 Nov 2021 //
FDA
Alexion`s Biologic Kanuma (sebelipase alfa) Receives Approval in the US
19 Nov 2021 //
FDA
Alexion Pharm`s Biological Ravulizumab-Cwvz Receives Approval In US
22 Apr 2021 //
FDA
Alexion`s Soliris (eculizumab) Receives Supplemental Approval in US
24 Nov 2020 //
FDA
Alexion`s Ultomiris (Ravulizumab-cwvz) Receives Supplemental Approval in US
14 Oct 2020 //
FDA
Alexion`s Strensiq (Asfotase Alfa) Receives Supplemental Approval in US
17 Jun 2020 //
FDA
Alexion`s Soliris (Eculizumab ) Receives Supplemental Approval in US
09 Apr 2020 //
FDA
Alexion`s Soliris (Eculizumab) Receives Supplemental Approval In US
07 Apr 2020 //
FDA
Alexion`s Ultomiris (Ravulizumab-Cwvz) Receives Supplemental Approval in US
19 Oct 2019 //
FDA
Alexion Europe SAS Ultomiris (Ultomiris) Receives Approval in Europe
11 Jul 2019 //
EMA
Alexion`s Ultomiris(Ravulizumab-Cwvz) Receives Supplemental Approval in US
21 Dec 2018 //
FDA
Alexion Pharm’s Soliris (Eculizumab) Receives Supplemental Approval In US
23 Oct 2017 //
FDA
Alexion Pharm`s Supplement Soliris (Eculizumab) Receives Approval In US
13 Jan 2017 //
FDA
Alexion`s Strensiq (asfotase alfa) approved in Europe for Hypophosphatasia
28 Sep 2015 //
EMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.